M-Quetiapine Fumarate XR 150 mg

M-Quetiapine Fumarate XR 150 mg is an extended-release tablet used for managing certain mental health conditions. This medication is designed to provide sustained relief and is manufactured by Mantra Pharma Inc in Canada.

M-Quetiapine Fumarate XR 150 mg is commonly used to treat symptoms associated with mental health disorders. It is often prescribed for conditions like schizophrenia or bipolar disorder, helping to stabilize mood and reduce psychotic symptoms. The extended-release formulation ensures a steady release of the active ingredient over time, which may help maintain consistent therapeutic effects.

M-Quetiapine Fumarate XR 150 mg may cause drowsiness, dizziness, or dry mouth in some individuals. These effects are generally mild and may diminish as the body adjusts to the medication. It is important to monitor how you feel when starting this medication and consult a healthcare provider if any effects are concerning.

Handle M-Quetiapine Fumarate XR 150 mg with care, especially if you have a history of low blood pressure, heart conditions, or seizures. Always follow the prescribed dosage and avoid activities that require alertness until you know how the medication affects you. Store the tablets in a cool, dry place away from direct sunlight.

M-Quetiapine Fumarate XR 150 mg may interact with other medications, including those that affect the central nervous system, such as alcohol or sedatives. It is also important to be cautious when taking this medication with drugs that are metabolized by the liver's CYP3A4 enzyme. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.